Risk of Total Events With Icosapent Ethyl: Can We Reduce It?

J Am Coll Cardiol. 2019 Jun 11;73(22):2803-2805. doi: 10.1016/j.jacc.2019.03.492.
No abstract available

Keywords: clinical trial; icosapent ethyl; recurrent events.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Eicosapentaenoic Acid* / analogs & derivatives
  • Humans
  • Hypertriglyceridemia*

Substances

  • eicosapentaenoic acid ethyl ester
  • Eicosapentaenoic Acid